Revisiting the IGF-1R as a Breast Cancer Target

npj Precision Oncology
doi 10.1038/s41698-017-0017-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

IGF-1R as an Anti-Cancer Target--Trials and Tribulations

Chinese Journal of Cancer
2013English

Molecular Imaging of IGF-1R in Cancer

Molecular Imaging
Nuclear MedicineRadiologyMolecular MedicineCondensed Matter PhysicsImagingBiotechnologyBiomedical Engineering
2017English

ALK and IGF-1R as Independent Targets in Crizotinib Resistant Lung Cancer

Scientific Reports
Multidisciplinary
2017English

Combinational Therapy Enhances the Effects of Anti-Igf-1r mAb Figitumumab to Target Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2015English

T-Darpp Activates IGF-1R Signaling to Regulate Glucose Metabolism in Trastuzumab-Resistant Breast Cancer Cells

Clinical Cancer Research
Cancer ResearchOncology
2017English

Can We Unlock the Potential of IGF-1R Inhibition in Cancer Therapy?

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2014English

Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

MicroRNA-320a Acts as a Tumor Suppressor in Endometrial Carcinoma by Targeting IGF-1R

International Journal of Molecular Medicine
MedicineGenetics
2019English

EP4 as a Therapeutic Target for Aggressive Human Breast Cancer

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy